Blepharoptosis: Unraveling this not-so-simple disorder

Article

Perhaps the most important consideration is understanding the neuromuscular pathway that retracts and protracts the eyelid.

A review1 of blepharoptosis indicates that this disorder is more complicated than meets the eye, in that blepharoptosis is not simply cosmetic; it also causes functional concerns that ultimately can affect the patient’s ability to perform daily activities and possibly leading to decreased quality of life, according to Matthew Floyd, MD, and Hee Joon Kim, MD, from the Department of Ophthalmology, Emory University, Atlanta.

“Blepharoptosis,” they explained, “is generally classified into categories based on the underlying pathogeneses: aponeurotic, myogenic, neurogenic, mechanical, and traumatic. Within these classifications, there are further subdivisions to aid diagnosis and management based on whether the ptosis is congenital or acquired, unilateral or bilateral, isolated or syndromic, or symptomatically driven by cosmetic or functional deficits.”

The most important consideration when attempting to unravel the underlying circumstances in cases of blepharoptosis is understanding the neuromuscular pathway that retracts and protracts the eyelid. “Ptosis often serves as a harbinger of underlying pathology along the neuromuscular pathway of the eyelid retractors,” Floyd and Kim explained.

They went on to pointed out that the elevation of the upper eyelid is a complex process in which 3 different retractors, specifically, the levator palpebrae superioris, Müller’s muscle, and the frontalis muscle, participate and each has its distinct innervation.

Any negative impact on these muscles can result in blepharoptosis.

Classifications

Of the 5 categories mentioned, aponeurotic, i.e., senile, is the most common; the levator palpebrae superioris chronically disinserts from the tarsal plate over time because of aging and gravity.

Myogenic ptosis also affects the levator palpebrae superioris and can be either congenital or acquired, acute or chronic, unilateral or bilateral, and isolated or syndromic; of these, congenital myogenic ptosis is the most common form in the US and UK. Investigations of isolated congenital myogenic ptosis point to “dysgenesis of the anterior portion of the levator palpebrae superioris with striated muscle fiber loss and loose connective tissue proliferation,” thus preventing the muscle from contract or relaxing, they explained.

Neurogenic ptosis is uncommon, accounting for from 5% to 15% of referrals in an oculoplastic practice, and secondary to an innervational deficit of the upper eyelid retractors. The primarily involved neural pathways are the oculomotor nerve (CN-III) and the sympathetic nervous system.

The most common acquired CN-III problem is microvascular ischemia associated with the risk factors of diabetes, hypertension, hyperlipidemia, and smoking; others include posterior communication aneurysm, giant cell arteritis, trauma, or squamous cell carcinoma. The most common form of congenital neurogenic ptosis is Marcus Gunn jaw-winking syndrome secondary to synkinesis. Congenital cranial dysinnervation disorders are rare causes of congenital neurogenic ptosis resulting from aberrant innervation of the facial and ocular musculature.

Mechanical ptosis prevents the upper eyelid from retracting because of a “mass effect preventing retraction under the orbital rim, cicatricial changes in the surrounding skin/conjunctiva, or a mass effect generating a downward force that cannot be overcome by the eyelid retractions. In adults, the most common acquired causes of ptosis are involutional brow ptosis, dermatochalasis, and large chalazia. In children, infectious pre- and post-septal cellulitis can cause substantial ptosis.

Traumatic ptosis can occur as the result of direct or indirect damage to the elevator palpebrae superioris, levator aponeurosis, Müller’s muscle, frontalis muscle, or the innervation that supplies these upper eye retractors, the authors explained. The injury can result from direct or indirect muscle injury, neurotoxins, a mass effect from scarring/foreign bodies, iatrogenic damage, cranial nerve damage, or cicatricial tethering of the skin.

Pseudoptosis can be caused often by dermatochalasis in which the skin of the upper eyelid hangs over the lashes, microphthalmos, enophthalmos, phthisis bulbi, voluntary ptosis, and synkinesis and must be differentiated from true ptosis.

The authors emphasized the importance of the patient evaluation that includes a subjective history, objective examination, and ancillary testing.

Determining the appropriate classification of the ptosis facilitates patient counseling and advice about treatment options, which includes surgery. “Ultimately the appropriate level of empathy and close patient-physician relationships are necessary [to ensure] patient satisfaction, given the often-challenging nature of repairing eyelid ptosis,” Floyd and Kim emphasized.

The authors have no financial interest in this subject matter.

Reference
1. Floyd MT, Kim HJ. More than meets the eye: a comprehensive review of blepharoptosis. Plast Aesthet Res. 2021;8:1.10.20517/2347-9264.2020.110

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
At CIME 2025, Selina McGee, OD, FAAO, says some patients underestimate oculoplastic care. She stands in front of a sign that says Controversies in Modern Eye Care 2025.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
© 2025 MJH Life Sciences

All rights reserved.